News & Events

Four lawyers of Faus & Moliner distinguished in the guide The Best Lawyers in Spain

The guide Best Lawyers has published its edition for the year 2020 for Spain

18 Dec 2019

The legal guide The Best Lawyers in Spain has recently launched its 12th edition for the year 2020, in which, on the basis of nominations...

The award ceremony was held on 27 June during a dinner at Complejo Duques de Pastrana

Faus Moliner

27 Jun 2019

Faus & Moliner has been recognized as the best Law Firm in life sciences in Spain at the Fourth Edition of the Awards granted by...

Jordi Faus delivers a presentation on the definition of the relevant product market in pharma competition law dossiers in light of the Servier case

Faus Moliner

27 Jun 2019

The 110th launch talk of the Global Competition Law Centre (GCLC) of the College of Europe was held in Brussels on 27 June. Jordi Faus...

Jordi Faus makes a presentation on the regulatory uncertainties between marketing authorization and reimbursement decisions

Faus Moliner

28 May 2019

In the last years, the Course on Pharmaceutical Law organized by Fundación CEFI has become a reference forum for the legal analysis of issues that...

Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2019

Faus Moliner

29 Mar 2019

Chambers and Partners has published the 2019 edition of the Chambers Europe Guide, in which, based on opinions of clients and other lawyers, the leading...

Jordi Faus made a presentation on the legal framework and new financing models in innovative therapies

Faus Moliner

28 Nov 2018

Faus & Moliner participated in the V Conference of the Roche Institute: “Towards a Health System based on the Creation of Value”, which was held...

Jordi Faus makes a presentation about offers, discounts and other commercial practices in the retail and hospital market

Faus Moliner

19 Sep 2018

The application of competition law to activities of the pharmaceutical sector raises specific challenges derived from special characteristics of this market. In this Seminar organized...

Jordi Faus makes a presentation on Equivalent Therapeutic Alternatives

Faus Moliner

18 Apr 2018

Jordi Faus makes a presentation in Madrid called ¿Are the lots by indication possible after the judgment of the Supreme Court on the Equivalent Therapeutic Alternatives (ETAs)?

Four lawyers of Faus & Moliner distinguished in the guide The Best Lawyers in Spain

The guide Best Lawyers has published its edition for the year 2020 for Spain

Faus & Moliner, recognized as the best Life Sciences Law Firm at the Fourth Edition of the Awards granted by Expansión Jurídico

The award ceremony was held on 27 June during a dinner at Complejo Duques de Pastrana

Faus & Moliner participates at the 110th Lunch Talk of the Global Competition Law Centre of the College of Europe

Jordi Faus delivers a presentation on the definition of the relevant product market in pharma competition law dossiers in light of the Servier case

Jordi Faus participates at the XVI Course on Pharmaceutical Law organized by CEFI

Jordi Faus makes a presentation on the regulatory uncertainties between marketing authorization and reimbursement decisions

Faus & Moliner continues to lead the pharmaceutical law in Spain

Jordi Faus, the best lawyer for pharmaceutical law in Spain according to the Chambers & Partners Guide 2019

Faus & Moliner participates in the V Conference of the Roche Institute: “Towards a Health System based on the Creation of Value”

Jordi Faus made a presentation on the legal framework and new financing models in innovative therapies

Faus & Moliner participates at the Seminar on practical issues of competition Law in the pharmaceutical sector organized by CEFI

Jordi Faus makes a presentation about offers, discounts and other commercial practices in the retail and hospital market

Faus & Moliner participates at the Conference Impact of the new Law on Public Sector Contracts in the pharmaceutical sector organized by CEFI

Jordi Faus makes a presentation on Equivalent Therapeutic Alternatives

Awards

Uso de cookies